Ritter G - Search Results

1

Effects of lifestyle modification programs on cardiac risk factors.

Razavi M, Fournier S, Shepard DS, Ritter G, Strickler GK, Stason WB. Razavi M, et al. Among authors: ritter g. PLoS One. 2014 Dec 9;9(12):e114772. doi: 10.1371/journal.pone.0114772. eCollection 2014. PLoS One. 2014. PMID: 25490202 Free PMC article.

2

Managed care and the quality of substance abuse treatment.

Shepard DS, Daley M, Ritter GA, Hodgkin D, Beinecke RH. Shepard DS, et al. J Ment Health Policy Econ. 2002 Dec;5(4):163-74. J Ment Health Policy Econ. 2002. PMID: 14578550

3

Gender and other factors associated with the nonmedical use of abusable prescription drugs.

Simoni-Wastila L, Ritter G, Strickler G. Simoni-Wastila L, et al. Among authors: ritter g. Subst Use Misuse. 2004 Jan;39(1):1-23. doi: 10.1081/ja-120027764. Subst Use Misuse. 2004. PMID: 15002942

4

Effects of a statewide carve out on spending and access to substance abuse treatment in Massachusetts, 1992 to 1996.

Shepard DS, Daley M, Ritter GA, Hodgkin D, Beinecke RH. Shepard DS, et al. Among authors: ritter ga. Health Serv Res. 2001 Dec;36(6 Pt 2):32-44. Health Serv Res. 2001. PMID: 16148959 Free PMC article.

5

Organizational and client determinants of cost in outpatient substance abuse treatment.

Beaston-Blaakman A, Shepard D, Horgan C, Ritter G. Beaston-Blaakman A, et al. Among authors: ritter g. J Ment Health Policy Econ. 2007 Mar;10(1):3-13. J Ment Health Policy Econ. 2007. PMID: 17417043

6

Benefits and costs of intensive lifestyle modification programs for symptomatic coronary disease in Medicare beneficiaries.

Zeng W, Stason WB, Fournier S, Razavi M, Ritter G, Strickler GK, Bhalotra SM, Shepard DS. Zeng W, et al. Among authors: ritter g. Am Heart J. 2013 May;165(5):785-92. doi: 10.1016/j.ahj.2013.01.018. Epub 2013 Mar 1. Am Heart J. 2013. PMID: 23622916

7

Effects of Expanded Coverage for Chiropractic Services on Medicare Costs in a CMS Demonstration.

Stason WB, Ritter GA, Martin T, Prottas J, Tompkins C, Shepard DS. Stason WB, et al. PLoS One. 2016 Feb 29;11(2):e0147959. doi: 10.1371/journal.pone.0147959. eCollection 2016. PLoS One. 2016. PMID: 26928221 Free PMC article.

8

The impact of the introduction of generic aromatase inhibitors on adherence to hormonal therapy over the full course of 5-year treatment for breast cancer.

Ma S, Shepard DS, Ritter GA, Martell RE, Thomas CP. Ma S, et al. Cancer. 2020 Aug 1;126(15):3417-3425. doi: 10.1002/cncr.32976. Epub 2020 Jun 2. Cancer. 2020. PMID: 32484941 Free article.

9

Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence.

Ma S, Shepard DS, Ritter GA, Martell RE, Thomas CP. Ma S, et al. PLoS One. 2021 May 18;16(5):e0250967. doi: 10.1371/journal.pone.0250967. eCollection 2021. PLoS One. 2021. PMID: 34003865 Free PMC article.

10

Association between medication adherence and non-drug healthcare utilisation and costs: a retrospective longitudinal cohort study among US women age 65 and older.

Ma S, Shepard DS, Ritter GA, Martell RE, Thomas C. Ma S, et al. BMJ Open. 2021 Dec 7;11(12):e052146. doi: 10.1136/bmjopen-2021-052146. BMJ Open. 2021. PMID: 34876428 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

610 results

Search Page

Filters